Published in Br J Nutr on June 01, 2000
Soup preloads in a variety of forms reduce meal energy intake. Appetite (2007) 1.10
Food form and portion size affect postprandial appetite sensations and hormonal responses in healthy, nonobese, older adults. Obesity (Silver Spring) (2009) 0.92
Effects of food form on food intake and postprandial appetite sensations, glucose and endocrine responses, and energy expenditure in resistance trained v. sedentary older adults. Br J Nutr (2011) 0.78
Calcium co-ingestion augments postprandial glucose-dependent insulinotropic peptide(1-42), glucagon-like peptide-1 and insulin concentrations in humans. Eur J Nutr (2013) 0.78
Failure of sucrose replacement with the non-nutritive sweetener erythritol to alter GLP-1 or PYY release or test meal size in lean or obese people. Appetite (2016) 0.75
Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell (2001) 25.86
A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res (1994) 2.80
Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis (2004) 2.64
Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring. J Hum Hypertens (1989) 2.32
Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol (2001) 2.02
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med (1999) 1.92
Deregulation of cyclin E in breast cancer. Oncogene (1995) 1.78
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res (2001) 1.76
Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology (1995) 1.74
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Reevaluation of duodenal endoscopic markers in the diagnosis of celiac disease. Gastrointest Endosc (2000) 1.62
Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med (1999) 1.55
Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med (1998) 1.53
Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation. Aliment Pharmacol Ther (2011) 1.49
High frequency of anti-endomysial reactivity in candidates to heart transplant. Dig Liver Dis (2002) 1.49
Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med (2001) 1.48
Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol (1991) 1.46
Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic. Aliment Pharmacol Ther (2012) 1.45
High prevalence but low pathogenicity of hepatitis G virus infection in Italian patients with genetic haemochromatosis. Ital J Gastroenterol Hepatol (1998) 1.42
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology (2000) 1.42
Fast variability of tera-electron volt gamma rays from the radio galaxy M87. Science (2006) 1.39
Heterogeneity of hemochromatosis in Italy. Gastroenterology (1998) 1.38
Non-alcoholic steatohepatitis. Report of five cases and review of the literature. Ital J Gastroenterol (1995) 1.38
Detection of gamma rays from a starburst galaxy. Science (2009) 1.38
Physical state of meal affects gastric emptying, cholecystokinin release and satiety. Br J Nutr (1998) 1.28
Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology (1999) 1.23
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology (2001) 1.21
Energy spectrum of cosmic-ray electrons at TeV energies. Phys Rev Lett (2008) 1.17
Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood (1997) 1.17
Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology (1992) 1.16
Increased prevalence of celiac disease in patients with dyspepsia. Arch Intern Med (2000) 1.14
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Blood orange juice inhibits fat accumulation in mice. Int J Obes (Lond) (2009) 1.11
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J Med Genet (2004) 1.11
The Sgs1 helicase of Saccharomyces cerevisiae inhibits retrotransposition of Ty1 multimeric arrays. Mol Cell Biol (2001) 1.10
Stainable iron in gastric and duodenal mucosa of primary hemochromatosis patients and alcoholics. Am J Gastroenterol (1987) 1.09
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology (1987) 1.06
Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test. Gut (1985) 1.05
Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood (1998) 1.04
Elective surgery for benign liver tumours. Cochrane Database Syst Rev (2007) 1.04
Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent. Biotechniques (1997) 1.02
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut (2008) 1.00
Weight, protein, fat, and timing of preloads affect food intake. Physiol Behav (1997) 0.98
Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterology (1995) 0.96
Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. Eur J Endocrinol (2003) 0.96
Celiac disease among patients referred for routine upper gastrointestinal endoscopy: prevalence and diagnostic accuracy of duodenal endoscopic markers. Am J Gastroenterol (2000) 0.95
Hepatic artery resistance in alcoholic liver disease. Hepatology (1998) 0.92
Transmembrane signals mediating neural peptide secretion: role of protein kinase C activators and arachidonic acid metabolites in luteinizing hormone-releasing hormone secretion. Endocrinology (1986) 0.92
Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Eur J Endocrinol (2005) 0.91
The influence of thermic effect of food on satiety. Eur J Clin Nutr (1998) 0.89
Haemochromatosis in patients with beta-thalassaemia trait. Br J Haematol (2000) 0.88
Chronic pulmonary histoplasmosis in a patient with a recent history of tuberculosis and persistent round lung lesions. Eur J Clin Microbiol Infect Dis (1999) 0.88
Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr (1999) 0.87
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. J Viral Hepat (2005) 0.87
Serological markers for coeliac disease: is it time to change? Dig Liver Dis (2001) 0.87
Nucleotide sequence of the genes encoding the canine herpesvirus gB, gC and gD homologues. J Gen Virol (1994) 0.87
Adult syncytial giant cell chronic hepatitis due to herbal remedy. J Hepatol (2000) 0.87
Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial. Digestion (1981) 0.86
HIV and HBV infection in intravenous drug addicts from northeastern Italy. J Med Virol (1987) 0.86
Lactose malabsorption and intolerance in Italians. Clinical implications. Dig Dis Sci (1986) 0.86
Wireless pH monitoring: better tolerability and lower impact on daily habits. Dig Liver Dis (2007) 0.86
Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology (1995) 0.85
Gastric involvement in a patient with secondary syphilis. Dig Liver Dis (2005) 0.85
Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J Clin Nutr (2004) 0.85
Circulating ghrelin levels in patients with inflammatory bowel disease. Gut (2006) 0.85
Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood (1998) 0.85
Gastric emptying and plasma neurotensin levels in untreated celiac patients. Scand J Gastroenterol (2000) 0.85
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis. J Viral Hepat (2013) 0.85
Influence of amiodarone on plasma and urine digoxin concentrations. Lancet (1984) 0.84
Correlations between C-reactive protein, interleukin-6, tumor necrosis factor-alpha and body mass index during senile osteoporosis. Arch Gerontol Geriatr (2008) 0.84
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology (1985) 0.84
Search for a dark matter annihilation signal from the galactic center halo with H.E.S.S. Phys Rev Lett (2011) 0.84
Late-onset idiopathic hypoparathyroidism as a cause of diarrhoea. Eur J Gastroenterol Hepatol (1998) 0.83
Redox properties of protein disulfide bond in oxidized thioredoxin and lysozyme: a pulse radiolysis study. Biochemistry (2000) 0.82
Portal hypertension and iron depletion in patients with genetic hemochromatosis. Hepatology (1995) 0.82
Pituitary adenylate cyclase-activating polypeptide regulates rat Leydig cell function in vitro. Neuropeptides (1997) 0.82
Gallbladder motility in obesity, diabetes mellitus and coeliac disease. Dig Liver Dis (2003) 0.82